Furthermore, similar finding has recently been reported by Li et al. (99), where reduction of ABCB1 abundance compared with the non-cancerous brain BBB was required to describe unbound PK profile of ribociclib in NE brain region of GBM patients. This evidence concerns the gene ABCB1 and glioblastoma.